This profile was last updated on //
Is this you? Claim your profile.
Massachusetts General Hospital
55 Fruit Street
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $785 m
Find other employees at this company (10,316)
(187 Total References)
Jeremy N. Ruskin, M.D., ...
Jeremy N. Ruskin, M.D., Professor of Medicine, Harvard Medical School; Director, Cardiac Arrhythmia Service, Massachusetts General Hospital
Jeremy Ruskin, ...
Jeremy Ruskin, MD
Chair of Scientific Advisory Board, Board Observer & Co-Founder
Dr. Ruskin is a world-renowned cardiologist and electrophysiologist.
He is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School.
Dr. Ruskin received his undergraduate degree from Tufts University and his medical degree from Harvard Medical School.
residency in Internal Medicine at Beth Israel Hospital
in Boston and his
fellowship in Cardiovascular Disease at the Massachusetts General Hospital
training in clinical and experimental cardiac electrophysiology at the USPHS Hospital
in Staten Island, New York under the mentorship of Dr. Anthony Damato.
Dr. Ruskin has trained more than 110 fellows in the subspecialty of cardiac arrhythmias over the past 38 years, many of whom are in leadership positions at academic centers throughout the world.
In addition, Dr Ruskin
is a much sought after speaker at medical conferences and has authored more than 450 original scientific publications, chapters, reviews, and monographs.
Dr. Ruskinâ€™s major research interests include: the mechanisms and management of atrial fibrillation; new antiarrhythmic drugs and innovative non-pharmacologic approaches to the treatment of atrial fibrillation; the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death; the role of arrhythmia control devices in the prevention of sudden cardiac death; the proarrhythmic effects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development.
In 1995, Dr. Ruskin founded the Annual International Atrial Fibrillation Symposium which he has directed since its inception and is the largest and longest running free-standing academic meeting on atrial fibrillation worldwide.
also maintains an active regional, national and international referral practice in the field of cardiac arrhythmias and electrophysiology and is recognized annually in Best Doctors in Boston and Best Doctors in America.
is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.
Finding Ways to Deliver a Life-Saving Jolt - News - InCube Labs, LLC.
"This is a problem of enormous public health dimensions," said Dr. Jeremy Ruskin, director of the cardiac arrhythmia service at Massachusetts General Hospital.
noted that more than 300,000 people in the United States die of sudden cardiac arrest every year.
"The bulk of these patients have underlying heart disease," he
said, "but the fact remains that the bulk of them could have lived significantly longer -- decades -- if not for a sudden electrical catastrophe."
The Ventritex and Medtronic defibrillators are "both superb devices," said Dr. Ruskin of Massachusetts General, who has installed 500 defibrillators in the last 10 years -- many of the early ones by C.P.I., but more recently using ones made by Ventritex and Medtronic, as well.
Faculty - AF Symposium 2016
Jeremy Ruskin, MD
Massachusetts General Hospital, Boston, MA
Jeremy Ruskin, MD is the ...
Jeremy Ruskin, MD is the Director of the Cardiac Arrhythmia Service in the Cardiology Division at MGH and Professor of Medicine at Harvard Medical School.
His clinical and research interests include cardiac arrhythmias and electrophysiology with a focus on new pharmacological and non-pharmacological approaches to the treatment of atrial fibrillation and the prevention of sudden cardiac death.
He assists with many research studies at the BHI involving cardiac care and is currently working on a study examining the effects of mind/body techniques on atrial fibrillation